A carregar...
Metastatic lung cancer in the age of targeted therapy: improving long-term survival
Epidermal growth factor receptor (EGFR) mutations are the most frequent targetable genetic abnormality observed in non-small cell lung cancer (NSCLC). More than a decade after EGFR mutations were shown to predict sensitivity to EGFR-tyrosine kinase inhibitors (EGFR-TKI), retrospective cohort studies...
Na minha lista:
| Publicado no: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233873/ https://ncbi.nlm.nih.gov/pubmed/28149768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.11.08 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|